Background Percutaneous coronary intervention (PCI) is frequently performed to reduce the
symptoms of stable angina. Whether PCI relieves angina more than a placebo procedure in …

Abstract The 2023 Multisociety Guidelines for the Management of Patients with Chronic
Coronary Disease (CCD) is a collaborative effort between the American Heart Association …

Aims The traditional approach to documenting angina outcomes in clinical trials is to ask the
patient to recall their symptoms at the end of a month. With the ubiquitous availability of …

Background Patients hospitalized with COVID-19 suffer thrombotic complications. Risk
factors for poor outcomes are shared with coronary artery disease. Objectives To investigate …

Background Percutaneous coronary intervention (PCI) for coronary chronic total occlusion
(CTO) has been performed for the improvement of symptoms and quality of life in patients …

We read with interest the recent description of the design and rationale of the ORBITA
(Objective Randomized Blinded Investigation with optimal medical Therapy of Angioplasty in …

The study aims to investigate the prognostic value of deep learning based pericoronary
adipose tissue attenuation computed tomography (PCAT) and plaque volume beyond …

We thank Milasinovic et al1 for their interest in our manuscript describing the design and
rationale of the ORBITA-2 trial2. In response to their comments, post-PCI invasive …

Debate. “Orbiting” around the management of stable angina. The clinician’s perspective |
Debate Advanced Search Impact Factor: 1.2 e-ISSN: 2604-7322 REC Publications Back …

Answer: The ORBITA trials focus on a specific aspect of the management of patients with
acute coronary syndrome: the benefit in terms of symptom relief of angina. 1, 2 The first …